These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8845691)

  • 21. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
    Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
    Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson disease psychosis: Update.
    Friedman JH
    Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotic symptoms in Parkinson's disease: pathophysiology and management.
    Bosboom JL; Wolters ECh
    Expert Opin Drug Saf; 2004 May; 3(3):209-20. PubMed ID: 15155149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
    Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
    Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach.
    Friedman JH
    Expert Opin Pharmacother; 2024 Feb; 25(2):149-156. PubMed ID: 38344806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease.
    Chacko RC; Hurley RA; Harper RG; Jankovic J; Cardoso F
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):471-5. PubMed ID: 8555750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal outcome of Parkinson's disease patients with psychosis.
    Factor SA; Feustel PJ; Friedman JH; Comella CL; Goetz CG; Kurlan R; Parsa M; Pfeiffer R;
    Neurology; 2003 Jun; 60(11):1756-61. PubMed ID: 12796526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief commentary: Under-recognition of underuse of clozapine in treating psychotic symptoms in Parkinson's disease.
    Friedman JH
    Schizophr Res; 2024 Jun; 268():282-284. PubMed ID: 37957037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
    Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
    Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of psychotic aspects of Parkinson's disease.
    Juncos JL
    J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.